The pediatric interventional cardiology devices market has been witnessing significant growth. This is due to rise in cardiovascular problems and other heart diseases among individuals. The pediatric interventional cardiology market is projected to register USD 1,379 million by 2018. Increased demand for treating specific cardiac ailments across various application sectors is estimated to propel the pediatric interventional cardiology market in the future.
The pivotal factor driving demand for this market is rising cases of congenital heart diseases. Innovative products are being introduced in the market and are expected to further the market. However, complexities in interventional cardiology devices and excise duty imposed on pediatric cardiology devices are anticipated to prevent the pediatric interventional cardiology devices market from progressing further.
The worldwide market is bifurcated into devices and geographies. The devices market is fragmented into transcatheter heart valves, closure devices of heart defect and others. The transcatheter heart valves market can be divided into transcatheter aortic valves and, transcatheter pulmonary valves.
The market for closure devices of heart defect is segregated into PFO (patent foramen ovales), VSD (ventricular septal defects) and ASD (atrial septal defects).The market for others is segmented into angioplasty balloons, angioplasty stents, guide wires and catheters. The worldwide pediatric interventional cardiology market is dominated by North America.
This is due to increase in technological advancements. Asia Pacific, Europe and rest of the world are expected to register fast growth over the coming years. The emerging markets of India and China have shown exponential pediatric interventional cardiology market growth. This owes to government support, improvements in healthcare infrastructure and huge investments by companies in pediatric interventional cardiology.